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Abstract
DNA methyltransferases (DNMTs) are key regulators of DNA methylation and have crucial roles in carcinogenesis,
embryogenesis and epigenetic modification. In general, DNMT1 has enzymatic activity affecting maintenance of DNA
methylation, whereas DNMT3A and DNMT3B are involved in de novo methylation events. Although DNMT genes are well
known in mammals including humans and mice, they are not well studied in avian species, especially the laying hen which
is recognized as an excellent animal model for research on human ovarian carcinogenesis. Results of the present study
demonstrated that expression of DNMT1, DNMT3A and DNMT3B genes was significantly increased, particularly in the
glandular epithelia (GE) of cancerous ovaries, but not normal ovaries. Consistent with this result, immunoreactive 5-
methylcytosine protein was predominantly abundant in nuclei of stromal and GE cells of cancerous ovaries, but it was also
found that, to a lesser extent, in nuclei of stromal cells of normal ovaries. Methylation-specific PCR analysis detected
hypermethylation of the promoter regions of the tumor suppressor genes in the initiation and development of chicken
ovarian cancer. Further, several microRNAs, specifically miR-1741, miR-16c, and miR-222, and miR-1632 were discovered to
influence expression of DNMT3A and DNMT3B, respectively, via their 39-UTR which suggests post-transcriptional regulation
of their expression in laying hens. Collectively, results of the present study demonstrated increased expression of DNMT
genes in cancerous ovaries of laying hens and post-transcriptional regulation of those genes by specific microRNAs, as well
as control of hypermethylation of the promoters of tumor suppressor genes.
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Introduction
Ovarian cancer is the most common malignancy in the female
genital tract in the United States, and the fifth leading cause of
cancer-related deaths among women. Of these, the surface
epithelial-derived ovarian cancer accounts for 90% of all ovarian
cancers [1]. Since the idea that the repeated rupture of the ovarian
epithelium during the monthly ovulation event in women may
contribute to accelerate the incidence of the epithelial ovarian
cancer was coined by Fathalla about 40 years ago [2], the etiology
of ovarian cancer is complicated and not fully understood.
However, results of a number of epidemiological studies indicate
that there is an increased ovarian cancer risk dependent on
ovulation frequency and reproductive factors [3]. Recently, the
early diagnosis of epithelial ovarian cancer and prediction of
prognosis for patient survival using specific biomarkers is in-
creasingly recognized as a better approach to identify this disease.
To overcome these limitations and obstacles and to elucidate the
etiology and pathogenesis of epithelial ovarian cancer, various
genetically engineered rodent models have been developed and
they are very useful; however, the artificial nature of the induced
tumors in rodents limits their clinical relevance [4,5,6]. Mean-
while, the laying hen is the only established animal model that
spontaneously develops ovarian surface epithelium-derived tu-
mors. In addition, cysts generation and epithelial dysplasia of the
surface epithelium of their ovaries is generally believed to be the
precursor of the epithelial-derived ovarian cancer associated with
number of ovulations as reported for humans [4]. Furthermore,
laying hen animal model shares a number of common pathological
features and histological subtypes with human ovarian cancer.
[4,5,7].
In higher organisms, DNA methylation plays pivotal roles in
normal growth/development and cellular differentiation and
affects a variety of biochemical events such as genomic
imprinting and X-chromosome inactivation [8]. In general,
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DNA methylation involves the addition of a methyl group to
the carbon 5 position (5 meC) of the cytosine residue in the
pyrimidine ring [9]. Thereby this modification has the specific
effect of reducing gene expression and can be inherited by
offspring. DNA methylation events in mammalian cells are
mainly carried out by two major classes of enzymatic activities;
maintenance methylation via DNA methyltransferase 1
(DNMT1) and de novo methylation via DNMT3A and
DNMT3B. In cancer biology, overexpression of DNMTs is
a hallmark of cancer cells such as endometrioid carcinomas and
prostate cancer [10,11,12] and it is responsible for aberrant
promoter hypermethylation of tumor suppressor genes in
various human cancer cells [13,14]. Although expression and
functional roles of DNMTs are well studied in mammalian
species, including humans and mice, little is known about their
expression and epigenetic regulation in avian species, especially
laying hens that develop epithelial ovarian cancer spontaneous-
ly. Therefore, the objectives of this study with laying hens were
to determine: 1) the expression of DNMTs in normal and
cancerous ovaries; and 2) whether DNMTs are regulated by
post-transcriptional actions of specific microRNAs using
a miRNA target validation assay. Our results confirm that the
laying hen is an established excellent model for research on
human ovarian cancer and that DNMTs may play a key role in
ovarian carcinogenesis.
Results
Patterns of Expression and Cell-specific Localization of
DNMT1, DNMT3A and DNMT3B mRNAs in Normal and
Cancerous Ovaries of Laying Hens
To determine if DNMTs are up- or down-regulated in ovarian
cancer cells of our laying hen model, we performed RT-PCR and
quantitative RT-PCR analyses. Results of the present study
identified three DNMT mRNAs that are unique to ovarian
carcinomas in laying hens (Figure 1A to –C). Further, quantitative
PCR revealed that expression of DNMT1, DNMT3A and
DNMT3B mRNAs increased 13.8- (P,0.01), 9.1- (P,0.05), and
2.7-fold (P,0.05) in the cancerous ovaries, respectively, as
compared with normal ovaries of laying hens (Figure 1D to –F).
Further, in situ hybridization analysis revealed that the three
DNMT mRNAs were abundantly expressed in glandular epithe-
lium (GE) of cancerous ovaries, but not in stroma and blood vessels
(Figure 1G to –I). Consistent with results of PCR analyses,
expression of DNMT mRNAs in GE of normal ovaries was
extremely weak.
DNA Methylation Patterns in Normal and Cancerous
Ovaries of Hens
To compare general methylation patterns in normal and
cancerous ovaries from laying hens, we performed immunohisto-
chemistry analysis using an antibody to 5-methylcytocine (5 meC).
As shown in Figure 2A, immunoreactive 5 meC protein was
localized in the GE and stromal cells of cancerous ovaries, and also
detected at low abundance in the stromal cells of normal ovaries.
Similarly, immunofluorescence staining demonstrated that immu-
noreactive 5 meC protein was predominantly abundant in nuclei
of stromal and GE cells of cancerous ovaries, but it was also found
that, to a lesser extent, in nuclei of stromal cells of normal ovaries
(Figure 2B). This indicates that GE cells in normal ovaries are not
undergoing DNA methylation, whereas GE cells in cancerous
ovaries have or are undergoing DNA methylation.
DNA Methylation Pattern of Promoter Regions of DNMTs
and Tumor Suppressor Genes
To investigate the DNA methylation status of the promoter
regions of selected tumor suppressor genes such as APC, CDKN2A,
PTEN, BRCA2, and RB1, we performed methylation-specific PCR
analysis. As illustrated in Figure 2C, the unmethylation status of
APC, CDKN2A, and RB1 is higher than their methylation status in
normal ovaries, whereas those genes are highly methylated in
cancerous ovaries. Similarly, the product band intensity of the
methylation or unmethylation statuses of the PTEN and BRCA2
promoter regions are equivalent in normal ovaries; but both
regions are predominantly methylated in cancerous ovaries.
Post-transcriptional Regulation of microRNA Affecting
DNMTs
Based on the possibility that expression of chicken DNMT genes
is regulated at the post-transcriptional level by microRNAs
(miRNAs), we performed a miRNA target validation assay.
Analysis of potential miRNA binding sites within the 39-UTR of
the each DNMT gene using the miRNA target prediction database
(miRDB; http://mirdb.org/miRDB/) revealed putative binding
sites for miR-148a and miR-1612 (for DNMT1); miR-1596, miR-
1687, miR-1741, and miR-1749 (for DNMT3A); and miR-16c, miR-
222, and miR-1632 (for DNMT3B). Therefore, we determined
whether these miRNAs influenced expressions of each DNMT
gene via its 39-UTR. A fragment of the 39-UTR of each gene
harboring binding sites for the miRNAs were cloned in
downstream of the green fluorescent protein (GFP) reading frame,
thereby creating a fluorescent reporter for function of the 39-UTR
region. After co-transfection of eGFP-39-UTR of each gene and
DsRed-miRNA, the intensity of GFP expression and percentage of
GFP-expressing cells were analyzed by fluorescence microscopy
and fluorescence activated cell sorting (FACS). As illustrated in
Figure 3, in the presence of miR-1741 for DNMT3A, the intensity
and percentage of GFP-expressing cells (100% in control vs.
73.15% in miR-1741) decreased (P,0.01). However, in the
presence of miR-1596, miR-1687, or miR-1749, neither the
intensity nor percentage of GFP-expressing cells changed (data
now shown). In addition, as shown in Figure 4, in the presence of
miR-16c, miR-222, or miR-1632 for DNMT3B, there was a decrease
(P,0.01) in the percentage of GFP-expressing cells (100% in
control vs. 85.3% in miR-16c, 40.3% in miR-222, and 25.9% in
miR-1632). In the presence of miR-148a or miR-1612 for DNMT1,
neither the intensity nor percentage of GFP-expressing cells
changed (data now shown). These results indicate that miR-1741,
miR-16c, miR-222, or miR-1632 directly bind to DNMT3A or
DNMT3B transcripts, respectively, and post-transcriptionally
regulate expression of the DNMT3A and DNMT3B genes.
Discussion
Key findings of the present study were that expression of the
DNMT1, DNMT3A and DNMT3B genes are abundantly expressed
only in GE of cancerous ovaries as compared to normal ovaries of
laying hens, and that expression of DNMT3A and DNMT3B genes
are post-transcriptionally regulated by miR-1741, miR-16c, miR-
222, or miR-1632, respectively. These results support our
hypothesis that DNMTs are critical regulators of initiation, growth
and development of epithelial-derived ovarian cancer in hens.
Generally, tumorigenesis is associated with accumulation of
genetic changes such as mutation, rearrangement, deletion and
translocations in genes. However, these classical theories alone
were unable to clarify the basis for carcinogenesis, and it is now
understood that epigenetic events involving multiple interactions
DNMTs in the Chicken Ovarian Cancinomas
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with DNMTs, small non-cording RNAs and tumor suppressor
genes likely lead to ovarian carcinogenesis. In the present study,
we mainly focused on multiple epigenetic mechanisms involved in
the regulation of DNMT genes in normal and cancerous ovaries of
laying hens, which are the most relevant animal model to identify
biomarkers of human ovarian cancer such as CA125, cytokeratin,
EGFR, Lewis Y, and erbB-2 and also expressed in carcinoma cells,
but not normal cells in ovaries of laying hens [15,16,17,18].
As a major epigenetic modification, DNA methylation affects
various biochemical processes such as regulation of gene
transcription, maintenance of genomic stability and imprinting,
and X-chromosome inactivation in mammals [19]. In fact, all
DNMTs have functional roles in regulation of DNA methylation.
DNMT1, as a member of the maintenance-type methyltransferase
family, consists of an N-terminal regulatory domain, glycine-lysine
repeat and C-terminal catalytic domains and is predominantly
responsible for hemimethylated CpG di-nucleotides in the
mammalian genome [20]. Indeed, appropriate expression of
DNMT1 is essential for the preservation of parental imprinting
[21]. For instance, in mice, although Dnmt12/2 embryonic stem
cells are viable, have no obvious abnormalities related to growth
rate or morphology and contain a small percentage of methylated
DNA and methyltransferase activity, the Dnmt12/2 embryos are
stunted in development and die during mid-gestation [22].
Furthermore, overexpression of DNMT1 is a hallmark of
endometrioid carcinomas and prostate cancer [10] and it is also
responsible for both de novo and maintenance methylation of tumor
suppressor genes in various human cancer cells [13]. On the other
hand, DNMT3A and DNMT3B could methylate hemimethylated
or unmethylated CpG islands at the same rate. Although the
general architecture of DNMT3 enzymes is very similar to that of
DNMT1, their total length is shorter than DNMT1 and they have
Figure 1. Expression, quantitation and localization of DNMTs in normal and cancerous ovaries from laying hens. [A–C] RT-PCR and [D–
F] q-PCR analyses were performed using cDNA templates from normal and cancerous ovaries of laying hens using chicken DNMT1, DNMT3A, DNMT3B
and GAPDH primers. The asterisks denote statistically significant differences (**P,0.01 and *P,0.05). [G–I] In situ hybridization analyses of DNMT
mRNAs in normal and cancerous ovaries of hens. Cross-sections of normal and cancerous ovaries of hens hybridized with antisense or sense chicken
DNMT cRNA probes. Legend: GE, glandular epithelium. See Materials and Methods for a complete description of the methods.
doi:10.1371/journal.pone.0061658.g001
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an unique tetrapeptide of proline-tryptophan-tryptophan-proline
(PWWP) motif [23]. Likewise Dnmt12/2, Dnmt3a2/2 and
Dnmt3b2/2 mice experience embryonic lethality during gestation
or early in the neonatal period due to hypomethylation of
pericentrimeric repeats [24]. In addition, overexpression of either
DNMT3A or DNMT3B is associated with tumorigenesis depend-
ing on cancer types in humans [11,12]. These results indicate that
both DNMT3A and DNMT3B function as de novo methyltrans-
ferases that play important roles in normal development and
disease.
Consistent with previous reports, results of the present study
demonstrate that expression levels of DNMT1, DNMT3A and
Figure 2. Methylation patterns of DNMTs and tumor suppressor genes in normal and cancerous ovaries from laying hens. [A and B]
Localization of 5-methylcytosine protein in normal and cancerous ovaries of hens. Sections were not counterstained. Arrows in panel B indicate nuclei
in the glandular epithelium of ovaries. [C] Methylation status of promoter regions of tumor suppressor genes using methylation-specific PCR analyses.
Legend: GE, glandular epithelium; M, methyl primer; U, unmethyl primer. See Materials and Methods for a complete description of the methods.
doi:10.1371/journal.pone.0061658.g002
Figure 3. In vitro target assay for microRNAs of the DNMT3A transcript. [A] Diagram of miR-1741 binding site in the DNMT3A 39-UTR. [B]
Expression vector map for eGFP with DNMT3A 39-UTR and Ds-Red with miR-1741. [C and D] After co-transfection of pcDNA-eGFP-39-UTR for the
DNMT3A transcript and pcDNA-DsRed-miRNA for the miR-1741, the fluorescence signals of GFP and DsRed were detected using FACS [C] and
fluorescent microscopy [D].
doi:10.1371/journal.pone.0061658.g003
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DNMT3B genes are significantly increased in cancerous as
compared with normal ovaries (Figure 1). Furthermore, all DNMT
mRNAs were predominantly abundant in GE of cancerous
ovaries. In fact, a number of complex glandular architectures
are usually found in various carcinomas that arise in various
organs such as stomach, bronchus, bladder, prostate, testis and
ovary due to the ubiquitous nature of glands. This is especially true
for ovaries of both avian and mammalian species, as these
glandular structures are mainly detected in the endometrioid-type
tumors with characteristics such as nuclear atypia, cribriform foci
and atresia of stromal follicles [4]. In addition, as illustrated in
Figures 2A and 2B, immunoreactive 5-methylcytosine protein was
predominantly abundant in the GE cells of cancerous ovaries
which indicate that these GE cells are undergoing DNA
methylation in response to increased expression of DNMTs.
Further, methylation-specific PCR data demonstrated that there
was a significant increase in methylation patterns of the promoter
regions of APC, CDKN2A, PTEN, BRCA2, and RB1 which are
tumor suppressor genes. These results support the idea that
epigenetic silencing of tumor suppressor genes by promoter CpG
island hypermethylation is one of the most important regulatory
mechanisms leading to the generation and proliferation of
carcinomas [25]. Recently, Socha and colleagues reported that
secreted protein acidic and rich in cysteine (SPARC) is down-
regulated in ovarian cancer through aberrant promoter hyper-
methylation [12]. Additionally, recent results demonstrated under-
expression of tumor suppressor genes in response to hypermethy-
lation on their promoter regions in various tumor types, such as
bladder, gastric and gynecological cancers [26,27,28]. Indeed,
global DNA hypomethylation and locus- and gene-specific DNA
hypermethylation have been implicated as hallmarks of many
cancers [29]. Likewise, results of the present study indicate that
silencing of APC, CDKN2A, PTEN, BRCA2 and RB1 genes by
promoter hypermethylation occurs in ovarian tumors, suggesting
the importance of changes in methylation patterns on the
promoter regions of these tumor suppressor genes in ovarian
carcinogenesis.
MicroRNAs (miRNAs) are small and non-coding RNAs of 18–
23 nucleotides in length that regulate gene expression post-
transcriptionally and alter cell fate by controlling translation of
target mRNAs in diverse tissues and cell types. Thus, miRNAs
play crucial roles in various biological processes including
vertebrate growth, development, differentiation and oncogenesis
by regulating gene expression [30]. In the present study, our
miRNA target validation assay demonstrated that in the presence
of miR-1741 for DNMT3A, the intensity and percentage of GFP-
expressing cells decreased (P,0.01), but this did not occur in the
presence of miR-1596, miR-1687, or miR-1749. Similarly, the
presence of miR-16c, miR-222, or miR-1632 for DNMT3B, the
percentage of GFP-expressing cells was decreased (P,0.01). These
results indicate that miR-1741, miR-16c, miR-222, or miR-1632
directly bind to the DNMT3A or DNMT3B transcript, respectively,
and post-transcriptionally regulate expression of those genes.
Collectively, results of the present study are the first to
demonstrate distinct cell-specific expression patterns for DNMTs
genes and determine the methylation status of CpG islands of
Figure 4. In vitro target assay of microRNAs on the DNMT3B transcript. [A] Diagram of miR-16c, miR-222, and miR-1632 binding sites in the
DNMT3B 39-UTR. [B] Expression vector map for eGFP with DNMT3B 39-UTR and Ds-Red with each miRNA. [C and D] After co-transfection of pcDNA-
eGFP-39-UTR for the DNMT3B transcript and pcDNA-DsRed-miRNA for the miR-16c, miR-222, and miR-1632, the fluorescence signals of GFP and DsRed
were detected using FACS [C] and fluorescent microscopy [D].
doi:10.1371/journal.pone.0061658.g004
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promoter regions of tumor suppressor genes between normal and
cancerous ovaries of laying hens. Further, our results revealed that
DNMT gene expression is post-transcriptionally regulated by
several miRNAs critical to ovarian carcinogenesis of laying hens.
DNA methylation is required for normal embryonic development,
X-chromosome inactivation and gene imprinting in mammalian
species and its aberrant effects leading to promoter hypermethyla-
tion of tumor suppressor genes by inappropriate expression of
DNMTs contributes to development of ovarian cancer. Therefore,
results of the present study provide new insights into DNMTs with
respect to epigenetic regulation and functional roles in ovarian
carcinogenesis in laying hens that are likely highly relevant to the
development of therapies for treatment of ovarian cancers in
humans.
Materials and Methods
Experimental Animals and Animal Care
The experimental use of chickens for this study was approved by
the Institute of Laboratory Animal Resources, Seoul National
University (SNU-070823-5). All White Leghorn (WL) chickens
were exposed to a light regimen of 15 h light and 9 h dark, ad
libitum access to feed and water, and standard management
practices for laying hens.
Tissue Samples
A total 136 laying hens (88 over 36 months and 48 over 24
months of age), which had completely stopped laying eggs were
euthanized for biopsy and cancerous (n = 10) ovaries were
collected. As a control, normal (n = 5) ovaries were also collected
from egg-laying hens. We examined the tumor stage in 10 hens
with cancerous ovaries using characteristic features of ovarian
cancer, based on the cellular subtypes and patterns of cellular
differentiation with reference to malignant tumor types in human
ovaries [4,31]. Three hens had stage III disease as ovarian tumor
cells had metastasized to the gastrointestinal (GI) tract and liver
surface with profuse ascites in the abdominal cavity. Five hens had
tumor cells spread to distant organs including liver parenchyma,
lung, GI tract and oviduct with profuse ascites, indicating stage IV
disease. Two hens had stage I disease as tumors were limited to
their ovaries.
RNA Isolation
Total cellular RNA was isolated from frozen tissues using Trizol
reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s
recommendations. The quantity and quality of total RNA was
determined by spectrometry and denaturing agarose gel electro-
phoresis, respectively.
Semi-quantitative RT-PCR Analysis
The level of expression of DNMT mRNAs in normal and
cancerous ovaries from chickens was assessed using semi-
quantitative as described previously [32]. Complementary DNA
(cDNA) was synthesized from total cellular RNA (2 ug) using
random hexamer (Invitrogen, Carlsbad, CA) and oligo (dT)
primers and AccuPowerH RT PreMix (Bioneer, Daejeon, Korea).
The cDNA was diluted (1:10) in sterile water before use in PCR.
After PCR, equal amounts of reaction product were analyzed
using a 1% agarose gel, and PCR products were visualized using
ethidium bromide staining.
Quantitative RT-PCR Analysis
Gene expression levels were measured using SYBRH Green
(Sigma, St. Louis, MO, USA) and a StepOnePlusTM Real-Time
PCR System (Applied Biosystems, Foster City, CA, USA) [33].
The GAPDH gene was simultaneously analyzed as a control and
used for normalization to account for variation in loading. Each
target gene and GAPDH was analyzed in triplicate. ROX dye
(Invitrogen) was used as a negative control for the fluorescence
measurements. Sequence-specific products were identified by
generating a melting curve in which the CT value represented
the cycle number at which a fluorescent signal was statistically
greater than background, and relative gene expression was
quantified using the 2–DDCT method [34]. For the control, the
relative quantification of gene expression was normalized to the
CT of the control ovary.
In Situ Hybridization Analysis
Location of mRNA in sections (5 mm) of chicken oviduct and
ovaries was determined by non-radioactive in situ hybridization
analysis as described previously [31]. After verification of the
sequences, plasmids containing the correct gene sequences were
amplified with T7- and SP6-specific primers and then digoxigenin
(DIG)-labeled RNA probes were transcribed using a DIG RNA
labeling kit (Roche Applied Science, Indianapolis, IN). After
hybridization and blocking, the sections were incubated overnight
with sheep anti-DIG antibody conjugated to alkaline phosphatase
(Roche). The signal was visualized by exposure to a solution
containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate,
0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma).
Immunohistochemistry
Immunocytochemical localization of 5-methylacytosine protein
in normal and cancerous ovaries from chickens was performed
using a mouse monoclonal antibody to 5-methylcytosine (catalog
number ab-10805; AbCam, CA, USA) at a final dilution of 1:200
(0.2 mg/ml) as described previously [33]. Negative controls
included substitution of the primary antibody with purified non-
immune mouse IgG at the same final concentration.
Immunofluorescence
Immunocytochemical localization of 5-methylacytosine protein
in normal and cancerous ovaries from chickens was performed
using a mouse monoclonal antibody to 5-methylcytosine (catalog
number ab-10805; Abcam, CA, USA) at a final dilution of 1:200
(0.2 mg/ml) as described previously [31].
Methylation-specific PCR (MSP) Analysis
To investigate differential methylation patterns of selected
tumor suppressor genes including APC gene (APC), cyclin-dependent
kinase inhibitor 2A (CDKN2A, also known as p16), phosphatase and tensin
homolog (PTEN), brac2 gene (BRCA2), and rb1 gene (RB1) between
normal and cancerous ovaries, we performed methylation-specific
PCR analysis. DNA samples were prepared using an AccuPrep
Genomic DNA Extraction Kit (Bioneer) and converted using
Epitect Bisulfite kit (QIAGEN, Doncaster, Australia) according to
the manufacturer’s instructions. PCR analyses were performed
with both a methylation-specific primer and an unmethylation-
specific primer for each gene with forward and reverse primers.
MicroRNA Target Validation Assay
The 39-UTRs of DNMTs were cloned and confirmed by
sequencing. Each 39-UTR was subcloned between the eGFP gene
and the bovine growth hormone poly-A tail in pcDNA3eGFP
(Clontech, Mountain View, CA) to generate the eGFP-miRNA
target 39-UTR (pcDNA-eGFP-39UTR) fusion constructs as de-
scribed previously [32]. For the dual fluorescence reporter assay,
DNMTs in the Chicken Ovarian Cancinomas
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the fusion contained the DsRed gene and either miR-148a or miR-
1612 for DNMT1; miR-1596, miR-1687, miR-1741, or miR-1749 for
DNMT3A; and miR-16c, miR-222, or miR-1632 for DNMT3B, and
each was designed to be co-expressed under control of the CMV
promoter (pcDNA-DsRed-miRNA). At 48 h post-transfection,
dual fluorescence was detected by fluorescence microscopy and
calculated by FACSCalibur flow cytometry (BD Biosciences). For
flow cytometry, the cells were fixed in 4% paraformaldehyde and
analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
Statistical Analyses
Data obtained using quantitative PCR analysis are presented as
mean 6 SEM unless otherwise stated. Differences in the variances
between normal and cancerous ovaries were analyzed using the F
test, and differences between means were subjected to the
Student’s t test. Differences with a probability value of P,0.05
were considered statistically significant.
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